|Articles|May 1, 2004
Phakic IOLs offer good outcomes to high myopes and hyperopes
The U.S. FDA study of the Implantable Collamer Lens (ICL, STAAR Surgical)used to treat high myopia (mean preoperative refraction, -10 D) and availablein four lengths (11.5 to 13 mm) shows good visual results in 526 eyes. Thesedata were presented at the American Society of Cataract and Refractive Surgery(ASCRS) annual meeting.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
NCX 470 gains positive regulatory feedback in China ahead of US NDA submission
2
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
3
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
4
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
5

















